Filing Details
- Accession Number:
- 0001203311-21-000002
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-08 19:52:23
- Reporting Period:
- 2021-01-07
- Accepted Time:
- 2021-01-08 19:52:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1060736 | Seagen Inc. | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | 21823 30Th Drive Se Bothell WA 98021 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-07 | 1,100 | $15.46 | 716,309 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 1,100 | $167.39 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 3,040 | $15.46 | 718,249 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 3,040 | $168.32 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 1,800 | $15.46 | 717,009 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 1,800 | $169.28 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 2,200 | $15.46 | 717,409 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 2,200 | $170.22 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 4,478 | $15.46 | 719,687 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 4,478 | $171.38 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 2,290 | $15.46 | 717,499 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 2,290 | $172.60 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 4,410 | $15.46 | 719,619 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 4,410 | $173.39 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 4,100 | $15.46 | 719,309 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 4,100 | $174.46 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 4,061 | $15.46 | 719,270 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 4,061 | $175.66 | 715,209 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-01-07 | 1,874 | $15.46 | 717,083 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-01-07 | 1,874 | $176.46 | 715,209 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-01-07 | 1,100 | $0.00 | 1,100 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-01-07 | 3,040 | $0.00 | 3,040 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-01-07 | 1,800 | $0.00 | 1,800 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-01-07 | 2,200 | $0.00 | 2,200 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-01-07 | 4,478 | $0.00 | 4,478 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-01-07 | 2,290 | $0.00 | 2,290 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-01-07 | 4,410 | $0.00 | 4,410 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-01-07 | 4,100 | $0.00 | 4,100 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-01-07 | 4,061 | $0.00 | 4,061 | $15.46 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2021-01-07 | 1,874 | $0.00 | 1,874 | $15.46 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 233,724 | 2021-08-24 | No | 4 | M | Direct | |
| 230,684 | 2021-08-24 | No | 4 | M | Direct | |
| 228,884 | 2021-08-24 | No | 4 | M | Direct | |
| 226,684 | 2021-08-24 | No | 4 | M | Direct | |
| 222,206 | 2021-08-24 | No | 4 | M | Direct | |
| 219,916 | 2021-08-24 | No | 4 | M | Direct | |
| 215,506 | 2021-08-24 | No | 4 | M | Direct | |
| 211,406 | 2021-08-24 | No | 4 | M | Direct | |
| 207,345 | 2021-08-24 | No | 4 | M | Direct | |
| 205,471 | 2021-08-24 | No | 4 | M | Direct |
Footnotes
- Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $166.85 to $167.80. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $167.85 to $168.78. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $168.85 to $169.84. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $169.88 to $170.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $170.95 to $171.93. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $171.99 to $172.97. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $172.99 to $173.98. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $174.09 to $175.07. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $175.13 to $176.08. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Reflects sales of common stock executed in multiple transactions at prices ranging from $176.20 to $176.81. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
- Options vested at a rate of 25% on 8/24/12 and monthly thereafter until all the shares were fully vested on 8/24/15.
Billionaire Hedge Funds
